Valuation : Celltrion, Inc.

Market Cap 44,904B 33.08B 28.46B 26.71B 24.43B 45.61B 3,127B 45.97B 316B 123B 1,598B 124B 122B 5,146B P/E 2026 *
28.4x
P/E 2027 * 24.6x
Enterprise Value 47.1B 34.7M 29.85M 28.01M 25.63M 47.84M 3.28B 48.22M 331M 129M 1.68B 130M 127M 5.4B EV / Sales 2026 *
8.58x
EV / Sales 2027 * 7.35x
Free-Float
60.59%
Yield 2026 *
0.41%
Yield 2027 * 0.44%
1 day+0.43%
1 week-2.20%
Current month-0.95%
1 month+2.69%
3 months+4.55%
6 months-12.69%
Current year+8.54%
1 week 184,200
Extreme 184200
191,300
1 month 184,200
Extreme 184200
212,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,247.57
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%-2.20%+14.55%+49.08% 33.08B
-1.32%-1.58%-0.62%+16.01% 50.35B
+0.78%-4.65%+430.22%+501.63% 45.2B
+2.95%+3.52%+47.12%+21.08% 44.71B
+0.25%-2.63%+7.86%+73.60% 41.24B
+1.43%+8.73% - - 17.81B
+0.06%-2.97%+23.31%+116.96% 16.56B
-0.44%+1.08%+16.50%+28.72% 14.82B
+0.54%-1.03%+80.71%+39.94% 14B
+2.34%-3.62%-9.13%-37.73% 12.62B
Average +0.70%-0.50%+67.84%+89.92% 29.04B
Weighted average by Cap. +0.63%-0.77%+87.94%+115.66%

Financials

2026 *2027 *
Net sales 5,488B 4.04B 3.48B 3.26B 2.99B 5.57B 382B 5.62B 38.61B 15.04B 195B 15.18B 14.85B 629B 6,302B 4.64B 3.99B 3.75B 3.43B 6.4B 439B 6.45B 44.34B 17.27B 224B 17.43B 17.05B 722B
Net income 1,501B 1.11B 951M 893M 817M 1.52B 105B 1.54B 10.56B 4.11B 53.42B 4.15B 4.06B 172B 1,742B 1.28B 1.1B 1.04B 948M 1.77B 121B 1.78B 12.26B 4.77B 62B 4.82B 4.71B 200B
Net Debt 2,199B 1.62B 1.39B 1.31B 1.2B 2.23B 153B 2.25B 15.47B 6.02B 78.24B 6.08B 5.95B 252B 1,409B 1.04B 893M 838M 767M 1.43B 98.11B 1.44B 9.91B 3.86B 50.14B 3.9B 3.81B 161B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-09-03 ₩187,100.00 +0.43% 406,507
26-09-02 ₩186,300.00 -0.90% 299,403
26-09-01 ₩188,000.00 -0.48% 268,440
26-08-31 ₩188,900.00 -0.94% 643,636
26-08-28 ₩190,700.00 -0.31% 375,920
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
187,100.00KRW
Average target price
266,031.64KRW
Spread / Average Target
+42.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock